Ghana's vice president discusses country's efforts to fight HIV/AIDS

Download PDF Copy

Jun 22 2011

NewsGuard 100/100 Score

John Dramani Mahama, vice president of the Republic of Ghana, recently spoke with NPR's "Tell Me More" about how Ghana has made significant gains against HIV/AIDS, bringing the prevalence rate down to 1.5 percent from nearly 4 percent. Mahama said the government is working with community organizations to educate the public, reduce stigma surrounding HIV/AIDS and eliminate mother-to-child transmission (Martin, 6/20).

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News | Healthcare News

Tags: AIDS, Health Care, HIV, HIV/AIDS, HIV-1, Research

Comments (0)

Download PDF Copy

Suggested Reading

Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus

Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus

Georgetown University receives $27.5 million grant to combat HIV/AIDS in Haiti

Georgetown University receives $27.5 million grant to combat HIV/AIDS in Haiti

Historical redlining continues to affect HIV treatment in affected communities

Historical redlining continues to affect HIV treatment in affected communities

Iron supplements may boost brain development in children with HIV

Iron supplements may boost brain development in children with HIV

Sweden exceeds UNAIDS HIV goals but faces new challenges

Sweden exceeds UNAIDS HIV goals but faces new challenges

New two-dose HIV vaccine strategy shows promise for stronger immune response

New two-dose HIV vaccine strategy shows promise for stronger immune response

Affordability and supply remain critical to the success of long-lasting HIV drug

Affordability and supply remain critical to the success of long-lasting HIV drug

New insights into the mechanisms of efavirenz-induced neurotoxicity

New insights into the mechanisms of efavirenz-induced neurotoxicity

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Study shows safety of kidney transplants among those with HIV infections